Mark K. Slifka

15.4k total citations · 3 hit papers
140 papers, 10.4k citations indexed

About

Mark K. Slifka is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Mark K. Slifka has authored 140 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Immunology, 40 papers in Infectious Diseases and 36 papers in Epidemiology. Recurrent topics in Mark K. Slifka's work include T-cell and B-cell Immunology (50 papers), Immune Cell Function and Interaction (44 papers) and Immunotherapy and Immune Responses (37 papers). Mark K. Slifka is often cited by papers focused on T-cell and B-cell Immunology (50 papers), Immune Cell Function and Interaction (44 papers) and Immunotherapy and Immune Responses (37 papers). Mark K. Slifka collaborates with scholars based in United States, Canada and France. Mark K. Slifka's co-authors include Ian J. Amanna, Rafi Ahmed, J. Lindsay Whitton, Nichole E. Carlson, Jason K. Whitmire, Erika Hammarlund, Rustom Antia, Ilhem Messaoudi, Carol Beadling and Janko Nikolich‐Žugich and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark K. Slifka

135 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Humoral Immunity Due to Long-Lived Plasma Cells

1998 954 citations Mark K. Slifka, Rafi Ahmed et al. profile →
Duration of Humoral Immunity to Common Viral and Vaccine Antigens

2007 880 citations Ian J. Amanna, Mark K. Slifka et al. profile →
Duration of antiviral immunity after smallpox vaccination

2003 691 citations Erika Hammarlund, Matthew W. Lewis et al. profile →

Peers

Mark K. Slifka

IMMUN

EPIDE

VIROL

Miles P. Davenport Australia

François Villinger United States

Pierre Lebon France

Christopher M. Walker United States

Heather L. Davis Canada

William W. Hall Ireland

Benhur Lee United States

Charles R. M. Bangham United Kingdom

Annette Oxenius Switzerland

Ulf Dittmer Germany

Miles P. Davenport Australia

Mark K. Slifka

4.7k ×0.8

IMMUN

1.8k ×0.7

EPIDE

2.0k ×0.9

4.3k ×2.1

2.3k ×1.5

VIROL

Citations per year, relative to Mark K. Slifka Mark K. Slifka (= 1×) peers Miles P. Davenport

Countries citing papers authored by Mark K. Slifka

Since Specialization

Citations

This map shows the geographic impact of Mark K. Slifka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Slifka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Slifka more than expected).

Fields of papers citing papers by Mark K. Slifka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark K. Slifka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Slifka. The network helps show where Mark K. Slifka may publish in the future.

Co-authorship network of co-authors of Mark K. Slifka

This figure shows the co-authorship network connecting the top 25 collaborators of Mark K. Slifka. A scholar is included among the top collaborators of Mark K. Slifka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark K. Slifka. Mark K. Slifka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rhoades, Nicholas S., et al.. (2024). Infant diarrheal disease in rhesus macaques impedes microbiome maturation and is linked to uncultured Campylobacter species. Communications Biology. 7(1). 37–37. 1 indexed citations

Amanna, Ian J., Archana Thomas, Flora Engelmann, et al.. (2024). Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model. Cell Reports Medicine. 5(7). 101655–101655. 5 indexed citations

Yates, Jennifer L., Danielle Hunt, Karen E. Kulas, et al.. (2023). Development of a novel serological assay for the detection of mpox infection in vaccinated populations. Journal of Medical Virology. 95(10). e29134–e29134. 10 indexed citations

Lyski, Zoë L., Myung Sun Kim, David X. Lee, et al.. (2022). Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia. SHILAP Revista de lepidopterología. 2022. 1–5. 2 indexed citations

Rhoades, Nicholas S., et al.. (2021). Longitudinal Profiling of the Macaque Vaginal Microbiome Reveals Similarities to Diverse Human Vaginal Communities. mSystems. 6(2). 14 indexed citations

Lyski, Zoë L., Amanda E. Brunton, Sarah Siegel, et al.. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of Concern. The Journal of Infectious Diseases. 225(6). 947–956. 12 indexed citations

Lyski, Zoë L., Myung Sun Kim, David X. Lee, et al.. (2021). Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia. Blood Advances. 6(4). 1207–1211. 11 indexed citations

Knox, James J., Marcus Buggert, Lela Kardava, et al.. (2017). T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response. JCI Insight. 2(8). 114 indexed citations

Hammarlund, Erika, et al.. (2012). Regulation of innate CD8 ⁺ T-cell activation mediated by cytokines. Proceedings of the National Academy of Sciences. 109(25). 9971–9976. 175 indexed citations

10.

Hammarlund, Erika, Matthew W. Lewis, Jon M. Hanifin, et al.. (2010). Antiviral Immunity following Smallpox Virus Infection: a Case-Control Study. Journal of Virology. 84(24). 12754–12760. 46 indexed citations

11.

Hirao, Lauren A., Ruxandra Draghia‐Akli, Maria Yang, et al.. (2010). Multivalent Smallpox DNA Vaccine Delivered by Intradermal Electroporation Drives Protective Immunity in Nonhuman Primates Against Lethal Monkeypox Challenge. The Journal of Infectious Diseases. 203(1). 95–102. 85 indexed citations

12.

Beadling, Carol & Mark K. Slifka. (2004). How do viral infections predispose patients to bacterial infections?. Current Opinion in Infectious Diseases. 17(3). 185–191. 144 indexed citations

13.

Gold, Marielle C., Michael W. Munks, Markus Wagner, et al.. (2004). Murine Cytomegalovirus Interference with Antigen Presentation Has Little Effect on the Size or the Effector Memory Phenotype of the CD8 T Cell Response. The Journal of Immunology. 172(11). 6944–6953. 61 indexed citations

14.

Slifka, Mark K., et al.. (2004). NK Markers Are Expressed on a High Percentage of Virus-Specific CD8+ and CD4+ T Cells. The Journal of Immunology. 172(11). 7220–7220. 1 indexed citations

15.

Liu, Fei, J. Lindsay Whitton, & Mark K. Slifka. (2004). The Rapidity with Which Virus-Specific CD8+ T Cells Initiate IFN-γ Synthesis Increases Markedly over the Course of Infection and Correlates with Immunodominance. The Journal of Immunology. 173(1). 456–462. 48 indexed citations

16.

Slifka, Mark K., Dirk Homann, Antoinette Tishon, Robb R. Pagarigan, & Michael B. A. Oldstone. (2003). Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection. Journal of Clinical Investigation. 111(6). 805–810. 46 indexed citations

17.

Slifka, Mark K., Joseph N. Blattman, David Sourdive, et al.. (2003). Preferential Escape of Subdominant CD8+ T Cells During Negative Selection Results in an Altered Antiviral T Cell Hierarchy. The Journal of Immunology. 170(3). 1231–1239. 35 indexed citations

18.

Rodrı́guez, Fernando, Stephanie Harkins, Mark K. Slifka, & J. Lindsay Whitton. (2002). Immunodominance in Virus-Induced CD8 ⁺ T-Cell Responses Is Dramatically Modified by DNA Immunization and Is Regulated by Gamma Interferon. Journal of Virology. 76(9). 4251–4259. 87 indexed citations

19.

Slifka, Mark K. & J. Lindsay Whitton. (2000). Activated and Memory CD8+ T Cells Can Be Distinguished by Their Cytokine Profiles and Phenotypic Markers. The Journal of Immunology. 164(1). 208–216. 149 indexed citations

20.

Slifka, Mark K., Robb R. Pagarigan, & J. Lindsay Whitton. (2000). NK Markers Are Expressed on a High Percentage of Virus-Specific CD8+ and CD4+ T Cells. The Journal of Immunology. 164(4). 2009–2015. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact